Behind the headlines
this week about Angelina Jolie’s preventive double mastectomy, another
issue lurked quietly in the background.
The superstar is also
at risk of developing ovarian cancer, a disease that’s harder to detect
than breast cancer and can be more lethal.
Women like Jolie who
have inherited the BRCA1 or BRCA2 gene mutations face significantly
higher rates of both types of cancer than other women. As a result, many
decide to have their ovaries and Fallopian tubes removed.
Jolie’s story went viral on Tuesday when an essay she wrote
about her decision to choose preventive surgery and breast
reconstruction was published in the New York Times. Most of the
discussion centred on her decision to have a double mastectomy and
breast reconstruction in a series of surgeries over the last three
months.
“The fact Jolie has
gone public with this is great, and I’m hoping it will continue to
highlight the BRCA mutation and the link to ovarian cancer,” said
Marilyn Sapsford, Ontario regional manager of Ovarian Cancer Canada, a non-profit advocacy and research group. “It’s a much less known disease, fewer women are aware of it.”
But Sapsford said it’s
critical women know the symptoms and understand that genetic testing
can be a proactive choice for those with a family history. It’s also
important that women who carry either of the BRCA gene mutations
associated with the two cancers talk to their doctors so they understand
their options for prevention.
They can also request a
referral to genetic counsellors who are trained to walk them through
every decision, from whether to proceed with genetic blood tests to
options if they carry a risk of hereditary cancer.
report from People. com on Wednesday said Jolie plans to have her ovaries removed, which reduces the risk of ovarian cancer to less than 5 per cent.
She made no mention of
that in her New York Times essay. However, she hinted there may be more
to come by explaining “I started with the breasts, as my risk of breast
cancer is higher than my risk of ovarian cancer.”
Jolie’s mother died of ovarian cancer at age 56.
What makes that cancer
so dangerous is that, unlike breast cancer, there are no reliable
screening tools to detect it. At the same time, symptoms mimic many
typical signs of premenstrual syndrome or menopause, so women often
dismiss them until the cancer is in advanced stages.
At that point, the
five-year survival rate is only 30 per cent, notes Sapsford. But when
caught early, there’s a 90 per cent chance of being cured, she said.
Faced with that
scenario, many women with the BRCA mutation opt for prophylactic
surgery, though younger women may delay until after having children.
“It’s something we
recommend because there’s no alternative option for screening,” says
Rochelle Demsky, one of three genetic counsellors at the familial breast and ovarian cancer clinic at Princess Margaret Hospital. “We usually advise it by age 40.”
Women with the BRCA
gene mutation have a lifetime risk of breast cancer ranging from 40 to
70 per cent, and their risk of ovarian cancer is between 10 and 40 per
cent. While the breast cancer risk is higher, so are chances of
survival.
But it’s important to
note those numbers vary according to specific family history, the
location of the mutation on the gene and other factors.
Demsky stresses that
decisions surrounding the two cancers are separate issues for women with
the mutation. There are more options to address the risk of breast
cancer. Discussion about removal of the ovaries tends to revolve around
age and family planning.
As surgical techniques
have advanced, women are increasingly opting for the preventive
mastectomy and reconstruction Jolie chose. However, many prefer a
regimen of screening through frequent mammograms and MRIs.
Breast surgery
generates far more discussion because it’s more controversial and
protracted, while oophorectomy to remove the ovaries is generally a day
surgery through laparoscopy. Recovery time is about a week, though the
side effects include premature menopause in younger women.
A blog detailing
Jolie’s decisions and medical procedures called “A Patient’s Journey:
Angelina Jolie” was launched Thursday by the Pink Lotus Breast Center in
Beverly Hills, where she is being treated.
“Many women
unfortunately do not know that BRCA gene mutations exist and could
affect them,” wrote breast cancer surgeon Dr. Kristi Funk.
“As Angelina says in her article, the important thing is to be aware of your options.”
No comments:
Post a Comment